EVENTS
Tuesday, June 8, 2021
1:00pm - 1:25pm EDT

CEO Saundra Pelletier provided an update on the commercialization of Phexxi® (lactic acid, citric acid and potassium bitartrate), the develoment of lead product candidate EVO100 for the...

STOCK INFORMATION
NASDAQEVFM
PRESS RELEASES
Jun 1, 2021

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Saundra Pelletier, Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows: Date: Friday,...

May 25, 2021

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that its CEO Saundra Pelletier will present at the 2021 LD Micro Invitational XI on Tuesday, June 8, 2021 at 1:00 p.m. ET (10:00 a.m. PT)....

May 21, 2021

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 50 million shares of its common stock and accompanying two-year...

May 17, 2021

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the pricing of its previously announced underwritten public offering of 50,000,000 shares of its common stock and accompanying short-term...

May 17, 2021

Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that it intends to offer and sell in an underwritten public offering, subject to market and other conditions, shares of its common stock (or...

Read More